Related Experiment Video
Updated: Jan 21, 2026

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
Published on: January 12, 2015
Progenitor Cells Derived from Drain Waste Product of Open-Heart Surgery in Children
Tak-Wah Wong1,2,3, Chung-Dann Kan4, Wen-Tai Chiu5
1Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Insights
Researchers discovered a novel source of human progenitor cells from pericardial effusion fluid. These cells, pericardial effusion-derived progenitor cells (PEPCs), show potential for cardiac repair and heart regeneration in preclinical models.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Stem Cell Research
Background:
- Autologous stem cell therapy offers potential advantages for cardiac repair.
- Identifying novel, accessible sources of human progenitor cells is crucial for regenerative medicine.
Purpose of the Study:
- To establish a new source of human progenitor cells from pericardial effusion fluid collected after pediatric open-heart surgery.
- To characterize the properties and therapeutic potential of these pericardial effusion-derived progenitor cells (PEPCs).
Main Methods:
- Collection and isolation of mononuclear cells from pericardial effusion fluid in 37 children.
- In vitro expansion and characterization of cells for cardiogenic lineage markers.
- Assessment of PEPC proliferation, angiogenesis enhancement, and in vivo efficacy in a mouse ischemic heart model.
Main Results:
- Pericardial effusion-derived progenitor cells (PEPCs) were successfully isolated and expanded, exhibiting cardiogenic markers and high proliferation.
- PEPCs enhanced angiogenesis in vitro and significantly improved cardiac ejection fraction in mice post-transplantation.
- Gene expression analysis indicated activation of paracrine signaling, cell migration, and angiogenesis in repaired hearts.
Conclusions:
- Pericardial effusion fluid is a viable source for obtaining human progenitor cells with regenerative potential.
- PEPCs demonstrate promise for promoting heart regeneration and functional recovery after ischemic injury.
- Further research into PEPCs could lead to new strategies for treating congenital heart diseases.
Abstract:
Human cardiac progenitor cells isolated from the same host may have advantages over other sources of stem cells. The aim of this study is to establish a new source of human progenitor cells collected from a waste product, pericardiac effusion fluid, after open-heart surgery in children with congenital heart diseases. The fluid was collected every 24 h for 2 days after surgery in 37 children. Mononuclear cells were isolated and expanded in vitro. These pericardial effusion-derived progenitor cells (PEPCs) exhibiting cardiogenic lineage markers, were highly proliferative and enhanced angiogenesis in vitro. Three weeks after stem cell transplantation into the ischemic heart in mice, cardiac ejection fraction was improved significantly without detectable progenitor cells. Gene expression profiles of the repaired hearts revealed activation of several known repair mechanisms including paracrine effects, cell migration, and angiogenesis. These progenitor cells may have the potential for heart regeneration.
More Related Videos
Related Concept Videos
Anatomy of the Heart
Anatomy of the Heart
The heart has three layers: the innermost endocardium, the muscular myocardium, and the outer epicardium, all working together for optimal cardiac function.
Chambers of the Heart
The heart is made up of four...
Differentiation of Common Myeloid Progenitor Cells
Drug Dosing: Infants and Children
Scalar Product (Dot Product)
The scalar product of two vectors is obtained by multiplying...
Vector Product (Cross Product)
Consider the cross product of two vectors. Imagine rotating the first vector about...

